107 related articles for article (PubMed ID: 471237)
1. [Use of raubasine in long-term therapy of obliterating arteriopathies].
Andreozzi GM; Signorelli S; Magnano V; Savoca N; Mazzerbo A; Cottini E; Sorrentino F
Minerva Cardioangiol; 1979; 27(1-2):61-6. PubMed ID: 471237
[No Abstract] [Full Text] [Related]
2. [Raubasine-peridural infiltration combination in therapy of obstructive arteriopathies of the lower extremities].
Giubbolini G; Setacci C; Romei R; Federici L
Minerva Cardioangiol; 1980 Mar; 28(3):177-82. PubMed ID: 7383367
[No Abstract] [Full Text] [Related]
3. [Clinico-instrumental evaluation of ciclonicate in the therapy of obliterating arteriopathies of the lower extremities in Fontaine's stage II].
Feliciotti F; De Carolis G; Mariotti C; Mingolla F
Ann Ital Chir; 1983; 55(5):493-7. PubMed ID: 6673630
[No Abstract] [Full Text] [Related]
4. [Ozone therapy, a new method of treating chronic obliterating arteriopathies].
Ionescu G; Pitea P; Blaj A
Rev Chir Oncol Radiol O R L Oftalmol Stomatol Chir; 1985; 34(3):207-13. PubMed ID: 2931752
[No Abstract] [Full Text] [Related]
5. [Intra-arterial infusion therapy in thrombo-obliterating diseases of the lower limbs].
Kurbangaleev SM; Savel'ev IuS
Vestn Khir Im I I Grek; 1974 Oct; 113(10):68-71. PubMed ID: 4432347
[No Abstract] [Full Text] [Related]
6. [Effects of buflomedil on peripheral arteriopathies. An open clinical study].
Longo FN; Potortì F; Urbano O; Perroni GB
Minerva Cardioangiol; 1988 May; 36(5):249-52. PubMed ID: 3059229
[No Abstract] [Full Text] [Related]
7. [Medical treatment of obliterating arteriopathies of the lower limbs with vasoactive drugs].
Raspanti D; Cameli AM; Trapani M; Dorigo D; Mazzotta A; Negro P
Clin Ter; 1987 Jun; 121(6):479-83. PubMed ID: 2973884
[No Abstract] [Full Text] [Related]
8. [Effect of an infusion of piribedil in normal subjects and in patients with peripheral obliterating arterial disease on the blood flow of the lower limbs and on blood, plasma and serum viscosity].
Forconi S; Guerrini M; Agnusdei D; Di Perri T
Minerva Med; 1976 May; 67(25):1671-80. PubMed ID: 934519
[No Abstract] [Full Text] [Related]
9. [Effects of the administration of buflomedil-hydrochloride on the arterial circulation of the legs in patients with obliterative arteriopathies].
Tallarida G; Baldoni F; Peruzzi G; Raimondi G; Grimaldi I; Visigalli G; Gristina S; Massaro M; De Martinis L; Sangiorgi M
Cardiologia; 1983 Aug; 28(8):651-60. PubMed ID: 6687209
[No Abstract] [Full Text] [Related]
10. [Acute effect of intravenous administration of raubasine on the peripheral pulse in patients with diabetic arterial diseases].
Calcaterra V
Minerva Cardioangiol; 1973; 21(7):530-44. PubMed ID: 4756347
[No Abstract] [Full Text] [Related]
11. [Medium term treatment with suloctidil in obliterating arteriopathies of the lower limbs. Personal experience].
Marongiu G; Dettori G; Gadeddu A; Noya G; Angius P; Biglioli P
Minerva Cardioangiol; 1983; 31(7-8):407-10. PubMed ID: 6316206
[No Abstract] [Full Text] [Related]
12. [Clinical experience with a new peripheral vasodilator agent, in which are combined raubasine, and 2 ergot alkaloids in the treatment of peripheral diabetic angiopathy].
Martínez-López JM; Calvo-Fernández R; Garrido-Toro A; Sánchez-Cañaveral F
Angiologia; 1973; 25(4):195-8. PubMed ID: 4717702
[No Abstract] [Full Text] [Related]
13. [Role and place of prolonged intra-arterial infusion in the treatment of obliterating arterial diseases of the lower extremities].
Belichenko IA; Kungurtsev VV; Dibirov MD
Khirurgiia (Mosk); 1980 Mar; (3):48-51. PubMed ID: 7366097
[No Abstract] [Full Text] [Related]
14. [Evaluation of the efficacy of medical treatment, especially anticoagulant treatment, in arteriopathies of the lower limbs. Apropos of 41 cases].
Chérif T; Kallel N; Guediche M
Tunis Med; 1986 May; 64(5):475-80. PubMed ID: 3824555
[No Abstract] [Full Text] [Related]
15. [Modification of cerebrovascular diseases through the oral administration of raubasine].
Klein K; Grübl M
Wien Med Wochenschr; 1974 Jun; 124(23):360-4. PubMed ID: 4599577
[No Abstract] [Full Text] [Related]
16. [Therapeutic effect of a combination of bufenine and beta-escine as an oral delayed-action drug in obliterating arterial diseases of the lower limbs].
Petruzzellis V; Scardigno A; Coviello C
Minerva Med; 1982 Feb; 73(5):181-6. PubMed ID: 7038552
[TBL] [Abstract][Full Text] [Related]
17. [Treatment with mesoglycan of chronic obliterative atherosclerotic arteriopathies of the legs. Hematochemical and flowmetric changes].
di Giovanna VN
Clin Ter; 1988 Jun; 125(6):431-4. PubMed ID: 2973949
[No Abstract] [Full Text] [Related]
18. [Short-term and long-term results of treatment of chronic arteriopathies of the lower limbs with nicergoline. Importance of intensive medical therapy].
Quiroli A
Minerva Cardioangiol; 1980 Dec; 28(12):793-804. PubMed ID: 6111767
[No Abstract] [Full Text] [Related]
19. [Clinical treatment of peripheral arterial occlusive diseases].
Schulte B
Fortschr Med; 1976 Sep; 94(27):1500-4. PubMed ID: 823087
[TBL] [Abstract][Full Text] [Related]
20. [Treatment of hyperdyslipidemia in chronic atherosclerotic peripheral obliterating arteriopathies of the lower limbs].
Bagliani A; Argenteri A; La Rosa A
Clin Ter; 1982 Dec; 103(6):647-61. PubMed ID: 7160147
[No Abstract] [Full Text] [Related]
[Next] [New Search]
